Future potential for anti-infectives from bacteria - How to exploit biodiversity and genomic potential.

International journal of medical microbiology : IJMM

PubMedID: 24119567

Müller R, Wink J. Future potential for anti-infectives from bacteria - How to exploit biodiversity and genomic potential. Int J Med Microbiol. 2013;.
The early stages of antibiotic development include the identification of novel hit compounds. Since actinomycetes and myxobacteria are still the most important natural sources of active metabolites, we provide an overview on these producers and discuss three of the most promising approaches toward finding novel anti-infectives from microorganisms. These are defined as the use of biodiversity to find novel producers, the variation of culture conditions and induction of silent genes, and the exploitation of the genomic potential of producers via "genome mining". Challenges that exist beyond compound discovery are outlined in the last section.